Penumbra PEN Thrombectomy — Revenue

Other product segments

Similar metrics at other companies

LENOther revenues — Revenue

$331.4M-6.8%

HRO

HROWOther Revenues — Revenue

$73K-15.1%

PRGOther Revenues — Revenue

$21.62M+165%

ORCLCloud Revenues — Revenue

$9.91B+47.1%

ORCLSoftware Revenues — Revenue

$6.82B-2.1%

OWLPerformance revenues — Revenue

$6.07M-3.9%

FAQ

What is Penumbra's thrombectomy — revenue?

Penumbra (PEN) reported thrombectomy — revenue of $253.92M in Q1 2026.

How has Penumbra's thrombectomy — revenue changed year-over-year?

Penumbra's thrombectomy — revenue increased by 12.1% year-over-year, from $226.54M to $253.92M.

What is the long-term trend for Penumbra's thrombectomy — revenue?

Over 4 years (2021 to 2025), Penumbra's thrombectomy — revenue has grown at a 21.3% compound annual growth rate (CAGR), from $437.78M to $947.92M.

What does thrombectomy — revenue mean?

This metric represents the total revenue generated from the sale of medical devices and systems specifically designed for thrombectomy procedures. It captures the market adoption and commercial performance of the company's specialized neurovascular and peripheral vascular intervention tools. This figure reflects the core top-line contribution from the firm's primary clinical focus area.